Matthew J Wongchenko (Matthew Wongchenko)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Locally Advanced

Gene Expression

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

Nature medicine

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Christopher J Sweeney, Russell Petry, Chang Xu, Merrida Childress, Jie He, David Fabrizio, Ole V Gjoerup, Samantha Morley, Timothy Catlett, Zoe June Assaf, Kobe Yuen, Matthew J Wongchenko, Kalpit Shah, Pratyush Gupta, Priti S Hegde, Lincoln W Pasquina, Sanjeev Mariathasan, Ryon P Graf, Thomas Powles
Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Rebecca A Dent, Sung-Bae Kim, Mafalda Oliveira, Carlos Henrique Barrios, Joyce O'Shaughnessy, Steven Jay Isakoff, Shigehira Saji, Rui Gilberto Ferreira, Manuel Philco, Igor Bondarenko, Qinshu Lian, Denise Bradley, Heather Hinton, Matthew J Wongchenko, Sarah-Jayne Reilly, Nicholas C Turner
Ipatasertib plus Paclitaxel for patients with PIK3CA/AKT1/PTEN-Altered Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer in the IPATunity130 Phase III Trial. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Manik Garg, Dominique-Laurent Couturier, Jeremie Nsengimana, Nuno A Fonseca, Matthew J Wongchenko, Yibing Yan, Martin Lauss, Göran B Jönsson, Julia Newton-Bishop, Christine Parkinson, Mark Ross Middleton, D Timothy Timothy Bishop, Sarah McDonald, Nikki Stefanos, John A Tadross, Ismael A Vergara, Serigne N Lô, Felicity Newell, James S Wilmott, John F Thompson, Georgina V Long, Richard A Scolyer, Pippa Corrie, David J Adams, Alvis Brazma, Roy Rabbie
Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomes. Nature communications 13 (1) (2022)
Zhen Shi, Julia Wulfkuhle, Malgorzata Nowicka, Rosa I Gallagher, Cristina Saura, Paolo G Nuciforo, Isabel Calvo, Jay Andersen, José Luis Passos-Coelho, Juan Miguel Gil-Gil, Begoña Bermejo, Debra A Pratt, Eva Ciruelos Gil, Patricia Villagrasa, Matthew J Wongchenko, Emanuel F Petricoin, Mafalda Oliveira, Steven Jay Isakoff
Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (5) (2022)
Manik Garg, Dominique-Laurent Couturier, Jeremie Nsengimana, Nuno A Fonseca, Matthew J Wongchenko, Yibing Yan, Martin Lauss, Göran B Jönsson, Julia Newton-Bishop, Christine Parkinson, Mark Ross Middleton, D Timothy Timothy Bishop, Sarah McDonald, Nikki Stefanos, John A Tadross, Ismael A Vergara, Serigne N Lô, Felicity Newell, James S Wilmott, John F Thompson, Georgina V Long, Richard A Scolyer, Pippa Corrie, David J Adams, Alvis Brazma, Roy Rabbie
Tumour gene expression signature in primary melanoma predicts long-term outcomes. Nature communications 12 (1) (2021)
Anneleen Daemen, Jonathan E Cooper, Szymon Myrta, Matthew J Wongchenko, Eva Lin, Jason E Long, Oded Foreman, Zora Modrusan, Jarrod R Tremayne, Cecile C de la Cruz, Mark Merchant, Scott E Martin, Yibing Yan, Melissa R Junttila
Transcriptional Subtypes Resolve Tumor Heterogeneity and Identify Vulnerabilities to MEK Inhibition in Lung Adenocarcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (4) (2020)
Antoni Ribas, Adil I Daud, Anna C Pavlick, Rene Gonzalez, Karl D Lewis, Omid Hamid, Thomas F Gajewski, Igor Puzanov, Matthew J Wongchenko, Isabelle Rooney, Jessie J Hsu, Yibing Yan, Erica Park, Grant A McArthur
Extended 5-Year Follow-up Results of a Phase Ib Study (BRIM7) of Vemurafenib and Cobimetinib in BRAF-Mutant Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (1) (2019)
Yibing Yan, Matthew J Wongchenko, Caroline Robert, James Larkin, Paolo Antonio Ascierto, Brigitte Dréno, Michele Maio, Claus Garbe, Paul B Chapman, Jeffrey A Sosman, Zhen Shi, Hartmut Koeppen, Jessie J Hsu, Ilsung Chang, Ivor Caro, Isabelle Rooney, Grant A McArthur, Antoni Ribas
Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib-treated Patients with BRAF V600-mutated Metastatic Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (11) (2019)
Jason E Long, Matthew J Wongchenko, Dorothee Nickles, Wei-Jen Chung, Bu-Er Wang, Johannes Riegler, Ji Li, Qingling Li, Wendy Sandoval, Jeff Eastham-Anderson, Zora Modrusan, Teemu Junttila, Richard A D Carano, Oded Foreman, Yibing Yan, Melissa R Junttila
Therapeutic resistance and susceptibility is shaped by cooperative multi-compartment tumor adaptation. Cell death and differentiation 26 (11) (2019)
Mattias Rydenfelt, Matthew J Wongchenko, Bertram Klinger, Yibing Yan, Nils Blüthgen
The cancer cell proteome and transcriptome predicts sensitivity to targeted and cytotoxic drugs. Life science alliance 2 (4) (2019)
Inês Pires da Silva, Kevin Y X Wang, James S Wilmott, Jeff Holst, Matteo S Carlino, John J Park, Camelia Quek, Matthew J Wongchenko, Yibing Yan, Graham J Mann, Douglas B Johnson, Jennifer Leigh McQuade, Rajat Rai, Richard F Kefford, Helen Rizos, Richard A Scolyer, Jean Yee Hwa Yang, Georgina V Long, Alexander M Menzies
Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (4) (2019)
Ryan J Sullivan, Omid Hamid, Rene Gonzalez, Jeffrey R Infante, Manish R Patel, F Stephen Hodi, Karl D Lewis, Hussein A Tawbi, Genevive Hernandez, Matthew J Wongchenko, YiMeng Chang, Louise Roberts, Marcus Ballinger, Yibing Yan, Edward Cha, Patrick Hwu
Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients. Nature medicine 25 (6) (2019)
Marie-Claire Wagle, Daniel Kirouac, Christiaan Klijn, Bonnie Liu, Shilpi Mahajan, Melissa Junttila, John Moffat, Mark Merchant, Ling Huw, Matthew J Wongchenko, Kwame Okrah, Shrividhya Srinivasan, Zineb Mounir, Teiko Sumiyoshi, Peter M Haverty, Robert L Yauch, Yibing Yan, Omar Kabbarah, Garret Hampton, Lukas Amler, Saroja Ramanujan, Mark R Lackner, Shih-Min A Huang
A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types. NPJ precision oncology 2 (1) (2018)
Matthew J Wongchenko, Antoni Ribas, Brigitte Dréno, Paolo A Ascierto, Grant A McArthur, Jorge D Gallo, Isabelle A Rooney, Jessie Hsu, Hartmut Koeppen, Yibing Yan, James Larkin
Association of programmed death ligand-1 (PD-L1) expression with treatment outcomes in patients with BRAF mutation-positive melanoma treated with vemurafenib or cobimetinib combined with vemurafenib. Pigment cell & melanoma research 31 (4) (2017)